Magnetic Resonance Imaging in Radiotherapy for Breast Cancer

Part of paid clinical trials in San Francisco, California.

Sponsor
University of California, San Francisco
Study ID
NCT05902507
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Magnetic Resonance Imaging Simulation — DIAGNOSTIC_TEST
    Radiographic Image Simulation

Study Details

This is a single-center, prospective pilot study evaluating feasibility and efficacy of incorporating magnetic resonance imaging (MRI) simulation into the planning of radiation treatment (RT) for breast cancer.

Key Dates

Start date
May 15, 2023
Status verified
Jun 2026
Primary completion
May 31, 2027
Completion
May 31, 2027

Study Design

Enrollment
20 participants (estimated)

Arms

  • Arm: Breast Cancer Participants
    Participants will receive both MRI and CT simulation scans.

Primary Outcome Measure

Percentage of participants who completed scan [ Time Frame: Day of MR imaging (1 day) ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of California, San FranciscoSan FranciscoCalifornia94143
[email protected]
877-827-3222
Lisa Singer, MD, PhD (PRINCIPAL_INVESTIGATOR)

Find similar trials in San Francisco, CA

By condition
Breast cancer
By specialty
OncologyBreast oncologyWomen's health
By research site
University of California, San Francisco· San Francisco, CA

Related Studies